Bank of America’s Biocept, Inc. BIOC Stock Holding History

Bank of America’s Portfolio BIOC Stock Details BIOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-18	Closed	-$287	–	8510
2022 Q4	$287	Buy	+18	New	+$397	﹤0.01%	7491
2021 Q4	–	Sell	-422	Closed	-$50K	–	8863
2021 Q3	$50K	Buy	422 +418	+10,450%	+$48.8K	﹤0.01%	7049
2021 Q2	$1K	Buy	4 +2	+100%	+$271	﹤0.01%	7681
2021 Q1	$0	Buy	+2	New	+$363	﹤0.01%	7917
2019 Q4	–	Sell	-3	Closed	-$1K	–	7533
2019 Q3	$1K	Buy	+3	New	+$864	﹤0.01%	7178
2019 Q1	–	Hold	0	–	–	–	7508
2018 Q4	–	Hold	0	–	–	–	7479
2018 Q3	–	Hold	0	–	–	–	7536
2017 Q1	–	Hold	0	–	–	–	7322
2016 Q4	–	Hold	0	–	–	–	7421
2016 Q3	–	Hold	0	–	–	–	7439
2016 Q2	–	Hold	0	–	–	–	7475
2016 Q1	–	Sell	-1	Closed	-$40K	–	7423
2015 Q4	$40K	Sell	1 -2	-67%	-$106K	﹤0.01%	6141
2015 Q3	$189K	Buy	3 +1	+50%	+$62.5K	﹤0.01%	5370
2015 Q2	$135K	Sell	2 -2	-50%	-$154K	﹤0.01%	5445
2015 Q1	$253K	Buy	+4	New	+$269K	﹤0.01%	4783
2014 Q3	–	Hold	0	–	-$8K	–	8233
2014 Q2	–	Hold	0	–	–	–	7547

Other funds holding BIOC

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TMWM

Taylor & Morgan Wealth Management Flint, Michigan $203M AUM 24.74% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Bank of America's BIOC Position: Q1 2023 in Review

Bank of America sold out of Biocept, Inc. (BIOC) in Q1 2023, closing a stake of 18 shares — an estimated $287 sold.

Bank of America first reported a position in BIOC in Q1 2015 and held it in 9 quarters. The position peaked at $253K in Q1 2015. 25 funds tracked by Wall St. Rank hold BIOC as of Q1 2023.

Bank of America reported no remaining Biocept, Inc. position as of Q1 2023 after selling out during the quarter.
Bank of America sold 18 Biocept, Inc. shares in Q1 2023, an estimated $287.
Bank of America first reported a position in Biocept, Inc. in Q1 2015 and held it in 9 quarters.
Bank of America's Biocept, Inc. position peaked at $253K in Q1 2015.
25 funds tracked by Wall St. Rank held Biocept, Inc. as of Q1 2023.

Based on Bank of America's 13F filing for Q1 2023, filed 12 May 2023.